All articles by Anthony King – Page 3
-
Business
Novo Holdings to buy contract manufacturer Catalent for $16.5 billion
Parent firm will then sell on three manufacturing sites to Novo Nordisk to boost capacity for diabetes and weight loss drugs
-
Research
Rare medical transmission of Alzheimer’s disease from donor to patient discovered
Human growth hormone extracted from cadavers passed disease protein to at least five people
-
Business
Nuclear power expansion plans highlight fuel bottlenecks
Western governments look to overcome Russian dominance of key uranium processing steps
-
Business
Danaher completes $5.7 billion Abcam acquisition
Deal proceeded despite significant opposition from founder and ex-chief Jonathan Milner
-
Business
Life-saving cancer gene therapy under investigation after being linked to rare secondary cancers
US drug agency examining six CAR-T therapies after reports of T-cell malignancies
-
Business
Northvolt to bring sodium-ion batteries to European market
Swedish firm highlights cells’ cheap and sustainable materials for energy storage
-
Business
Weight-loss drug shortages prompt copycats and counterfeits
Novo Nordisk and Eli Lilly have struggled to meet huge demand for new hormone mimic obesity treatments
-
News
Irish PhD researchers left disappointed as stipend raise is just half of what was hoped for
Independent review recommended increasing stipends to €25,000 but they rose to just €22,000
-
Research
Field study reveals banned pesticide sulfoxaflor had no effect on pollination by bumblebees
Work adds to nuanced picture of pesticide’s effect on pollinating insects
-
Research
Genetic-editing of chickens protects them from catching the flu
Approach heralds new way to make animals resistant to disease
-
Research
Mutation studies reveal how Antarctic octopus arms itself with cool enzyme
Understanding cold-tolerant enzyme could help with transplant organ preservation
-
Research
’This is just the beginning’: RNA editing set to democratise viral engineering
Crispr-based system could ease development of novel RNA therapies
-
Business
Tornado at Pfizer plant accentuates US drug shortage issues
Perennial problem will not be addressed without major reforms to drug market
-
News
Horizon deal looks to have come too late for 2023 winners of EU grants in UK
European Research Council award winners still face unenviable choice of deciding between their grant and their UK institution
-
Research
Lithium discovery in US volcano could be biggest deposit ever found
Find could point to new ways to prospect for material in high demand for batteries.
-
News
Hungarian scientists left in the lurch as government’s battle with EU drags on
Backsliding on democratic principles led to Orbán’s government being suspended from EU research programmes
-
Business
Illumina’s Grail quest results in epic fine
EU and US competition authorities object to firms completing merger without approval
-
Research
Tell-tale protein fragment discovered in Alzheimer’s patients could be basis for blood test
Tau protein fragment could track progress of the disease
-
News
Pay rise for PhDs in Ireland, but failure to tackle other issues sees strike action threatened
Independent review recommends €25,000 salaries – however, questions over employment status and visas remain unanswered
-
News
European Commission set to propose an overhaul of rules for gene-edited crops
Leaked document reveals light touch regulation planned for crops engineering using precision techniques